SHC icon

Sotera Health

16.39 USD
+0.09
0.55%
At close Updated Sep 17, 10:19 AM EDT
1 day
0.55%
5 days
3.87%
1 month
3.73%
3 months
49.68%
6 months
37.38%
Year to date
20.34%
1 year
-1.62%
5 years
-34.7%
10 years
-34.7%
 

About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Employees: 3,000

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

121% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 47

63% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 30

10% more funds holding in top 10

Funds holding in top 10: 10 [Q1] → 11 (+1) [Q2]

8% more funds holding

Funds holding: 205 [Q1] → 222 (+17) [Q2]

0.61% more ownership

Funds ownership: 95.08% [Q1] → 95.7% (+0.61%) [Q2]

4% less capital invested

Capital invested by funds: $3.14B [Q1] → $3.02B (-$123M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$13
21% downside
Avg. target
$13
21% downside
High target
$13
21% downside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Barclays
Luke Sergott
$13
Overweight
Maintained
24 Jun 2025

Financial journalist opinion

Neutral
GlobeNewsWire
13 days ago
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 20,000,000 shares of its common stock, par value $0.01 per share. All 20,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement.
Sotera Health Announces Secondary Offering of Common Stock
Positive
Zacks Investment Research
20 days ago
Should You Buy Sotera Health Company (SHC) After Golden Cross?
Sotera Health Company (SHC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SHC's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Should You Buy Sotera Health Company (SHC) After Golden Cross?
Neutral
Zacks Investment Research
1 month ago
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
Neutral
Seeking Alpha
1 month ago
Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q2 2025 Earnings Conference Call August 8, 2025 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Jonathan M. Lyons - Senior VP & CFO Michael B.
Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
1 month ago
Sotera Health (SHC) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Sotera Health (SHC) Q2 2025 Earnings Transcript
Neutral
The Motley Fool
1 month ago
Sotera Health (SHC) Q2 Revenue Up 6%
Sotera Health (SHC) Q2 Revenue Up 6%
Sotera Health (SHC) Q2 Revenue Up 6%
Neutral
GlobeNewsWire
1 month ago
Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results
CLEVELAND, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2025.
Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results
Positive
Zacks Investment Research
1 month ago
Exploring Analyst Estimates for Sotera Health (SHC) Q2 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sotera Health (SHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Exploring Analyst Estimates for Sotera Health (SHC) Q2 Earnings, Beyond Revenue and EPS
Neutral
GlobeNewsWire
1 month ago
Sotera Health Announces Second-Quarter 2025 Earnings Release Date
CLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the second-quarter ended June 30, 2025 before the market opens on Friday, August 8, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights.
Sotera Health Announces Second-Quarter 2025 Earnings Release Date
Neutral
GlobeNewsWire
1 month ago
Trends Shaping Qatar's Infection Control Market 2025-2034: Featuring Sidra Medicine, BD, Condair, Sotera Health, Olympus, 3M
The Qatar infection control market is driven by automated and AI-powered sterilization systems. Rising hospital admissions, awareness of healthcare-associated infections, and advanced disinfection technologies further propel growth. The Qatar infection control market is driven by automated and AI-powered sterilization systems. Rising hospital admissions, awareness of healthcare-associated infections, and advanced disinfection technologies further propel growth.
Trends Shaping Qatar's Infection Control Market 2025-2034: Featuring Sidra Medicine, BD, Condair, Sotera Health, Olympus, 3M
Charts implemented using Lightweight Charts™